Phenobarbital as a Sedation Strategy to Reduce Opioid and Benzodiazepine Burden in Neonatal Extracorporeal Membrane Oxygenation
American Journal of Perinatology · 2024-08 · 41 (11) · 1586-1591
DOI: 10.1055/s-0044-1779255 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Perinatology, online erschienen am 16.02.2024. Verfasst von Vilmaris Quinones Cardona und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neonatology, Department of Pediatrics, St. Christopher's Hospital for Children, Philadelphia, Pennsylvania. Hauptthemen laut MEDLINE: Phenobarbital, Extracorporeal Membrane Oxygenation, Hypnotics and Sedatives, Analgesics, Opioid. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
Objective
The study aims to describe our experience with the implementation of phenobarbital as a primary sedation strategy during neonatal extracorporeal membrane oxygenation (ECMO). Study Design Retrospective chart review in a level IV neonatal intensive care unit between 2011 and 2021 comparing neonatal ECMO patients before and after the implementation of a sedation-analgesia (SA) protocol using scheduled phenobarbital as the primary sedative. Groups were compared for neonatal and ECMO characteristics, cumulative SA doses, and in-hospital outcomes. Comparison between groups was performed using Mann–Whitney test on continuous variables and chi-square on nominal variables.
Results
Forty-two patients were included, 23 preprotocol and 19 postprotocol. Birth, pre-ECMO, and ECMO clinical characteristics were similar between groups except for a lower birth weight in the postprotocol group (p = 0.024). After standardization of phenobarbital SA protocol, there was a statistically significant reduction in median total morphine dose (31.38–17.65 mg/kg, p = 0.006) and median total midazolam dose (36.21–6.36 mg/kg, p < 0.001). There was also a reduction in median total days on morphine by 7.5 days (p = 0.026) and midazolam by 6.6 days (p = 0.003). There were no differences in ECMO duration or in-hospital outcomes between groups.
Conclusion
In this cohort, short-term use of phenobarbital as primary sedation strategy during neonatal ECMO was associated with reduced opioid and midazolam burden. Such reduction, however, did not affect in-hospital outcomes. Key Points
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Neonatology, Department of Pediatrics, St. Christopher's Hospital for Children, Philadelphia, Pennsylvania.
- Department of Pediatrics, Drexel University College of Medicine, Philadelphia, Pennsylvania.
ORCID-Profile: Vilmaris Quinones Cardona, Emma Byrne
Zitieren
APA
Cardona, V. Q., Byrne, E., Mejia, M., Joshi, S., & Menkiti, O. (2024). Phenobarbital as a Sedation Strategy to Reduce Opioid and Benzodiazepine Burden in Neonatal Extracorporeal Membrane Oxygenation. American Journal of Perinatology, 41(11), 1586-1591. https://doi.org/10.1055/s-0044-1779255
Vancouver
Cardona VQ, Byrne E, Mejia M, Joshi S, Menkiti O. Phenobarbital as a Sedation Strategy to Reduce Opioid and Benzodiazepine Burden in Neonatal Extracorporeal Membrane Oxygenation. American Journal of Perinatology. 2024;41(11):1586-1591. doi:10.1055/s-0044-1779255
BibTeX
@article{Cardona2024,
author = {Cardona, Vilmaris Quinones and Byrne, Emma and Mejia, Michelle and Joshi, Swosti and Menkiti, Ogechukwu},
title = {Phenobarbital as a Sedation Strategy to Reduce Opioid and Benzodiazepine Burden in Neonatal Extracorporeal Membrane Oxygenation},
journal = {American Journal of Perinatology},
year = {2024},
volume = {41},
number = {11},
pages = {1586--1591},
doi = {10.1055/s-0044-1779255}
}
EUVIMED